ACTAVIA LIFE SCIENCES, INC. financial data

Location
New York, NY
Fiscal year end
30 September
Latest financial report
10-Q - Q1 2024 - 20 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity 20% % -93%
Return On Assets -784% % 89%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 771,811,360 shares 0%
Common Stock, Shares, Outstanding 771,811,360 shares 8.4%
Common Stock, Value, Issued $771,811 USD 0%
Weighted Average Number of Shares Outstanding, Basic 771,811,360 shares 31%
Weighted Average Number of Shares Outstanding, Diluted 771,811,360 shares 31%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $90,330 USD 1.3%
General and Administrative Expense $254,937 USD -15%
Operating Income (Loss) $345,267 USD 92%
Net Income (Loss) Attributable to Parent $406,646 USD 92%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $48,614 USD -7%
Liabilities, Current $2,230,363 USD 16%
Retained Earnings (Accumulated Deficit) $28,906,757 USD -1.4%
Stockholders' Equity Attributable to Parent $2,181,749 USD -17%
Liabilities and Equity $48,614 USD -7%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 1,500,000,000 shares 0%
Common Stock, Shares, Issued 771,811,360 shares 8.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,392 USD -37%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $25,953,197 USD 0.37%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%